SCHEMBL3514617

SCHEMBL3514617

O=c1cc(O)c2cccnc2n1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 3/20 0.47
DAO P14920 1/20 0.44
FTO Q9C0B1 2/20 0.41
KDM4E B2RXH2 9/20 0.39
L3MBTL1 Q9Y468 5/20 0.39
HSP90AA1 P07900 3/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
NPSR1 Q6W5P4 2/20 0.39
IDO1 P14902 2/20 0.39
MAPT P10636 2/20 0.39
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM6B O15054 1/20 0.39
KDM6A O15550 1/20 0.39
TET3 O43151 1/20 0.39
KDM4A O75164 1/20 0.39
KDM4B O94953 1/20 0.39
KDM5C P41229 1/20 0.39
KDM4D Q6B0I6 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3516135 0.81 FEN1 (0.46) FEN1DAOKDM4EHSP90AA1IDO1
SCHEMBL5871967 0.81 FEN1 (0.54) FEN1FTOKDM4ENPSR1MAPT
SCHEMBL5872072 0.79 KDM4E (0.60) FEN1KDM4ENPC1RAB9ANPSR1
SCHEMBL2409501 0.78 FEN1 (0.57) FEN1MAPTKMT2AALDH1A1SMN1; SMN2
SCHEMBL4460861 0.78 FEN1 (0.47) FEN1DAOKMT2AALDH1A1HTT
SCHEMBL18136095 0.78 FEN1 (0.47) FEN1DAOFTOKDM4EMEN1
SCHEMBL3517544 0.76 FEN1 (0.42) FEN1DAOKDM4EL3MBTL1NPC1
SCHEMBL3517754 0.76 PIK3CD (0.52) FEN1DAOMEN1KMT2A
SCHEMBL5872017 0.75 ALDH1A1 (0.51) FEN1KDM4EMAPTMEN1KMT2A
SCHEMBL829931 0.74 MEN1 (0.63) KDM4EL3MBTL1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10980754-B2 Anti-fungal compounds SAINT LOUIS UNIVERSITY (US) 2021-04-20 US disclosed
US-20190099385-A1 ANTI-FUNGAL COMPOUNDS SAINT LOUIS UNIVERSITY (US) 2019-04-04 US disclosed
WO-2017184752-A1 ANTI-FUNGAL COMPOUNDS SAINT LOUIS UNIVERSITY (US) 2017-10-26 WO disclosed
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK SHARP & DOHME CORP. 2010-03-04 US disclosed
WO-2008010964-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS MERCK & CO., INC. (US) 2008-01-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100056516-A1 1-HYDROXY NAPHTHYRIDINE COMPOUNDS AS ANTI-HIV AGENTS RNASEH1, RNASE1, RNASEL FEN1 115/4885DAO 3247/4885FTO 3677/4885
US-20190099385-A1 ANTI-FUNGAL COMPOUNDS ERG28, NANS, DPM1 FEN1 1355/4885DAO 1179/4885FTO 3816/4885
US-10980754-B2 Anti-fungal compounds ERG28, NANS, DPM1 FEN1 1355/4885DAO 1179/4885FTO 3816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.